Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 6 |
NetGPI | no | yes: 0, no: 6 |
Related structures:
AlphaFold database: A4HP91
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 182 | 184 | PF00675 | 0.514 |
CLV_NRD_NRD_1 | 363 | 365 | PF00675 | 0.628 |
CLV_NRD_NRD_1 | 367 | 369 | PF00675 | 0.643 |
CLV_NRD_NRD_1 | 90 | 92 | PF00675 | 0.314 |
CLV_PCSK_FUR_1 | 364 | 368 | PF00082 | 0.601 |
CLV_PCSK_KEX2_1 | 182 | 184 | PF00082 | 0.514 |
CLV_PCSK_KEX2_1 | 365 | 367 | PF00082 | 0.639 |
CLV_PCSK_PC1ET2_1 | 365 | 367 | PF00082 | 0.639 |
CLV_PCSK_SKI1_1 | 254 | 258 | PF00082 | 0.508 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.422 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.380 |
DOC_CKS1_1 | 308 | 313 | PF01111 | 0.471 |
DOC_CYCLIN_RxL_1 | 91 | 101 | PF00134 | 0.356 |
DOC_MAPK_gen_1 | 72 | 80 | PF00069 | 0.396 |
DOC_MAPK_gen_1 | 91 | 97 | PF00069 | 0.335 |
DOC_PP2B_LxvP_1 | 266 | 269 | PF13499 | 0.535 |
DOC_PP2B_LxvP_1 | 95 | 98 | PF13499 | 0.435 |
DOC_USP7_MATH_1 | 175 | 179 | PF00917 | 0.592 |
DOC_USP7_MATH_1 | 187 | 191 | PF00917 | 0.541 |
DOC_USP7_MATH_1 | 218 | 222 | PF00917 | 0.646 |
DOC_USP7_MATH_1 | 252 | 256 | PF00917 | 0.571 |
DOC_USP7_MATH_1 | 279 | 283 | PF00917 | 0.532 |
DOC_USP7_MATH_1 | 53 | 57 | PF00917 | 0.610 |
DOC_WW_Pin1_4 | 11 | 16 | PF00397 | 0.416 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.623 |
DOC_WW_Pin1_4 | 234 | 239 | PF00397 | 0.382 |
DOC_WW_Pin1_4 | 264 | 269 | PF00397 | 0.683 |
DOC_WW_Pin1_4 | 307 | 312 | PF00397 | 0.667 |
DOC_WW_Pin1_4 | 33 | 38 | PF00397 | 0.420 |
LIG_14-3-3_CanoR_1 | 117 | 127 | PF00244 | 0.300 |
LIG_14-3-3_CanoR_1 | 166 | 172 | PF00244 | 0.661 |
LIG_14-3-3_CanoR_1 | 57 | 66 | PF00244 | 0.555 |
LIG_14-3-3_CanoR_1 | 77 | 81 | PF00244 | 0.286 |
LIG_Actin_WH2_2 | 151 | 168 | PF00022 | 0.414 |
LIG_FHA_1 | 118 | 124 | PF00498 | 0.364 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.401 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.594 |
LIG_FHA_1 | 344 | 350 | PF00498 | 0.454 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.376 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.358 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.469 |
LIG_FHA_2 | 65 | 71 | PF00498 | 0.381 |
LIG_LIR_Gen_1 | 237 | 247 | PF02991 | 0.437 |
LIG_LIR_Gen_1 | 329 | 334 | PF02991 | 0.494 |
LIG_LIR_Nem_3 | 105 | 111 | PF02991 | 0.456 |
LIG_LIR_Nem_3 | 237 | 243 | PF02991 | 0.426 |
LIG_LIR_Nem_3 | 329 | 333 | PF02991 | 0.493 |
LIG_SH2_GRB2like | 142 | 145 | PF00017 | 0.467 |
LIG_SH2_STAP1 | 82 | 86 | PF00017 | 0.366 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.458 |
LIG_SH3_3 | 166 | 172 | PF00018 | 0.606 |
LIG_SH3_5 | 98 | 102 | PF00018 | 0.538 |
LIG_SUMO_SIM_anti_2 | 76 | 83 | PF11976 | 0.444 |
LIG_SUMO_SIM_par_1 | 14 | 20 | PF11976 | 0.524 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.543 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.580 |
MOD_CK1_1 | 267 | 273 | PF00069 | 0.702 |
MOD_CK1_1 | 284 | 290 | PF00069 | 0.516 |
MOD_CK1_1 | 329 | 335 | PF00069 | 0.610 |
MOD_CK1_1 | 355 | 361 | PF00069 | 0.700 |
MOD_CK1_1 | 76 | 82 | PF00069 | 0.456 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.490 |
MOD_CK2_1 | 187 | 193 | PF00069 | 0.663 |
MOD_CK2_1 | 64 | 70 | PF00069 | 0.385 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.702 |
MOD_GlcNHglycan | 254 | 257 | PF01048 | 0.711 |
MOD_GlcNHglycan | 273 | 276 | PF01048 | 0.509 |
MOD_GlcNHglycan | 312 | 315 | PF01048 | 0.724 |
MOD_GlcNHglycan | 355 | 358 | PF01048 | 0.567 |
MOD_GlcNHglycan | 51 | 54 | PF01048 | 0.595 |
MOD_GSK3_1 | 182 | 189 | PF00069 | 0.577 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.651 |
MOD_GSK3_1 | 260 | 267 | PF00069 | 0.727 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.392 |
MOD_GSK3_1 | 310 | 317 | PF00069 | 0.595 |
MOD_GSK3_1 | 352 | 359 | PF00069 | 0.480 |
MOD_GSK3_1 | 49 | 56 | PF00069 | 0.510 |
MOD_N-GLC_1 | 271 | 276 | PF02516 | 0.792 |
MOD_N-GLC_1 | 284 | 289 | PF02516 | 0.463 |
MOD_N-GLC_2 | 198 | 200 | PF02516 | 0.528 |
MOD_NEK2_1 | 116 | 121 | PF00069 | 0.375 |
MOD_NEK2_1 | 146 | 151 | PF00069 | 0.403 |
MOD_NEK2_1 | 153 | 158 | PF00069 | 0.406 |
MOD_NEK2_1 | 262 | 267 | PF00069 | 0.635 |
MOD_NEK2_1 | 353 | 358 | PF00069 | 0.557 |
MOD_NEK2_1 | 49 | 54 | PF00069 | 0.497 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.369 |
MOD_NEK2_1 | 90 | 95 | PF00069 | 0.326 |
MOD_NEK2_2 | 187 | 192 | PF00069 | 0.533 |
MOD_PIKK_1 | 118 | 124 | PF00454 | 0.364 |
MOD_PKA_1 | 182 | 188 | PF00069 | 0.523 |
MOD_PKA_2 | 116 | 122 | PF00069 | 0.312 |
MOD_PKA_2 | 182 | 188 | PF00069 | 0.523 |
MOD_PKA_2 | 203 | 209 | PF00069 | 0.656 |
MOD_PKA_2 | 343 | 349 | PF00069 | 0.455 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.596 |
MOD_PKA_2 | 73 | 79 | PF00069 | 0.502 |
MOD_PKA_2 | 90 | 96 | PF00069 | 0.354 |
MOD_Plk_1 | 279 | 285 | PF00069 | 0.524 |
MOD_Plk_4 | 3 | 9 | PF00069 | 0.371 |
MOD_ProDKin_1 | 11 | 17 | PF00069 | 0.406 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.629 |
MOD_ProDKin_1 | 234 | 240 | PF00069 | 0.379 |
MOD_ProDKin_1 | 264 | 270 | PF00069 | 0.683 |
MOD_ProDKin_1 | 307 | 313 | PF00069 | 0.672 |
MOD_ProDKin_1 | 33 | 39 | PF00069 | 0.418 |
MOD_SUMO_rev_2 | 31 | 37 | PF00179 | 0.476 |
TRG_DiLeu_BaLyEn_6 | 91 | 96 | PF01217 | 0.408 |
TRG_ENDOCYTIC_2 | 155 | 158 | PF00928 | 0.435 |
TRG_ER_diArg_1 | 364 | 367 | PF00400 | 0.597 |
TRG_NLS_MonoCore_2 | 363 | 368 | PF00514 | 0.599 |
TRG_NLS_MonoExtC_3 | 363 | 368 | PF00514 | 0.599 |
TRG_NLS_MonoExtN_4 | 362 | 369 | PF00514 | 0.595 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P7A7 | Leptomonas seymouri | 44% | 96% |
A0A3Q8IW00 | Leishmania donovani | 71% | 99% |
A4IDJ6 | Leishmania infantum | 70% | 99% |
E9ASZ9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 99% |
Q4Q1J9 | Leishmania major | 69% | 100% |